Overview
Fellowship Details
The 2027 Postdoctoral Fellowship in Pharmaceutical Policy Research will prepare talented emerging scholars for careers in law, public policy, health outcomes research, or public health related to prescription drugs. Previous fellows have gone on to successful careers in academia, government, and the private sector.
Fellows will be expected to design, conduct, publish, and present original research during their fellowship term. Research topics include FDA drug or device regulation; pharmaceutical intellectual property policy; prescription drug coverage and benefit design; drug pricing, value, and cost-effectiveness; comparative effectiveness and outcomes research; evidence-based prescribing; and competition in the pharmaceutical market. Fellows receive close faculty mentorship and interact with policymakers, regulators, and other stakeholders. PORTAL research is routinely cited in the media and by policymakers, offering added career development opportunities.
This position is benefits-eligible with an annual salary typically ranging from $70,000–$80,000 based on post-graduate year and experience, per the FY27 Mass General Brigham Research Salary Scale.
Applicants should hold a doctoral degree (PhD, JD, MD, PharmD, or equivalent) or complete such training by September 1, 2027. Fellow start date and fellowship length will vary depending on the candidate (1-year minimum, typically 2 years). Visa sponsorship may be available for international applicants. Fellows are expected to live in the Boston area for the fellowship’s duration.
To Apply
Submit the following materials via the application form by 11:59pm ET on December 11, 2026:
- A cover letter describing your past work, research interests, and career goals
- A CV
- A writing sample (e.g., a first-authored research paper, a dissertation chapter, or an excerpt from a course assignment)
Select candidates will be contacted for interviews after the deadline. Questions? Contact Matt Martin (mmartin55@bwh.harvard.edu).
Mass General Brigham and Harvard Medical School are Equal Opportunity Employers. All qualified applicants will receive consideration without regard to race, color, religious creed, national origin, sex, age, gender identity, disability, sexual orientation, military service, genetic information, and/or other status protected under law. Applications from groups underrepresented in medicine, law, policy, and health services research are strongly encouraged.
About Program On Regulation, Therapeutics, And Law (PORTAL)
Established in 2012, PORTAL is a leading academic research center dedicated to studying the regulation, use, evidence, and affordability of prescription drugs. Led by six Harvard Medical School faculty from a variety of disciplines, PORTAL brings together expertise in medicine, law, epidemiology, health policy, economics, and ethics to conduct rigorous research that informs policymaking. Learn more about PORTAL.
PORTAL is based in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, at Brigham and Women's Hospital, an interdisciplinary, 90-member research hub focused on improving our understanding of prescription drug safety and effectiveness since 1998.